Evaluation of the Protective Effect of Citral, Silymarin, and Thymoquinone on Methotrexate-Induced Lung Injury in Rats
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Several studies have reported that methotrexate is an anti-cancer and immunosuppressive drug leading to lung injury. Therefore, the present study aimed to investigate the protective effects of silymarin, citral, and thymoquinone on methotrexate-induced pulmonary toxicity. Methods: Forty-eight rats were divided into six groups, including healthy, Methotrexate, and drug carrier control groups and silymarin, citral, and thymoquinone treatment groups. At the end of the experiment, the studied rats were anesthetized and sacrificed by CO 2 . Lung tissue samples were isolated to measure the antioxidant activity and histopathological evaluation. Results: In the thymoquinone treatment group, the concentration of total antioxidant capacity and Malondialdehyde increased and decreased significantly, respectively, compared to the methotrexate group. The histopathological evaluation of the lung of the methotrexate group showed hemorrhage and congestion, the nodule-like accumulation of mononuclear inflammatory lymphocytes around the blood vessel, a small number of neutrophils around the blood vessel, and the inflammatory cells around the small vessels. However, no significant pathological alterations were observed in the treatment groups, especially the thymoquinone treatment group. Conclusion: Thymoquinone has the greatest protective effect on methotrexate-induced lung injury, probably due to its antioxidant effect.
Abstract
Objectives: Several studies have reported that methotrexate is an anti-cancer and immunosuppressive drug leading to lung injury. Therefore, the present study aimed to investigate the protective effects of silymarin, citral, and thymoquinone on methotrexate-induced pulmonary toxicity. Methods: Forty-eight rats were divided into six groups, including healthy, Methotrexate, and drug carrier control groups and silymarin, citral, and thymoquinone treatment groups. At the end of the experiment, the studied rats were anesthetized and sacrificed by CO 2 . Lung tissue samples were isolated to measure the antioxidant activity and histopathological evaluation. Results: In the thymoquinone treatment group, the concentration of total antioxidant capacity and Malondialdehyde increased and decreased significantly, respectively, compared to the methotrexate group. The histopathological evaluation of the lung of the methotrexate group showed hemorrhage and congestion, the nodule-like accumulation of mononuclear inflammatory lymphocytes around the blood vessel, a small number of neutrophils around the blood vessel, and the inflammatory cells around the small vessels. However, no significant pathological alterations were observed in the treatment groups, especially the thymoquinone treatment group. Conclusion: Thymoquinone has the greatest protective effect on methotrexate-induced lung injury, probably due to its antioxidant effect.
참고문헌 (41)
- Conway R, "Methotrexate and lung disease in rheumatoid arthritis", Panminerva Med, 59(1), pp.33~46 (2017)
- Hanoodi M, "Stat-Pearls" (2022), StatPearls Publishing
- Nowicki TS, "Early recognition of renal toxicity of high-dose methotrexate therapy : a case report", J Pediatr Hematol Oncol, 30(12), pp.950~952 (2008)
- Sotoudehmanesh R, "Methotrexate hepatotoxicity in patients with rheumatoid arthritis", Middle East J Dig Dis, 2(2), pp.104~109 (2010)
- Perez-Verdia A, "Acute cardiac toxicity associated with high-dose intravenous methotrexate therapy : case report and review of the literature", Pharmacotherapy, 25(9), pp.1271~1276 (2005)
- Koppelmann T, "Dietary L-arginine supplementation reduces Methotrexate-induced intestinal mucosal injury in rat", BMC Gastroenterol, 12, pp.41~ (2012)
- Kaymak E, "Vitamin B12 alleviates methotrexate-induced lung injury in rat : a histopathological, immunohistochemical and biochemical study", Turk Bull Hyg Exp Biol, 79(1), pp.81~92 (2022)
- Chhabra P, "Methotrexate induced lung injury in a patient with primary CNS lymphoma : a case report", Mediterr J Hematol Infect Dis, 4(1), pp.e2012020~ (2012)
- Karadag AS, "Pulmonary fibrosis developed secondary to methotrexate use in a patient with psoriasis vulgaris", North Clin Istanb, 2(2), pp.159~161 (2015)
- Ademola C. Famurewa, "Beneficial role of virgin coconut oil supplementation against acute methotrexate chemotherapy-induced oxidative toxicity and inflammation in rats", Integrative Medicine Research, 7(3), pp.257~263 (2018), 한국한의학연구원[DOI]
- Asci H, "The impact of gallic acid on the methotrexate-induced kidney damage in rats", J Food Drug Anal, 25(4), pp.890~897 (2017)
- Yucel Y, "The effects of lycopene on methotrexate-induced liver injury in rats", Bratisl Lek Listy, 118(4), pp.212~216 (2017)
- Pınar N, "The protective effects of alpha lipoic acid on methotrexate induced testis injury in rats", Biomed Pharmacother, 97, pp.1486~1492 (2018)
- Idrees M, "Natural bio-active compounds. Vol. 3, Biotechnology, bioengineering, and molecular approaches", pp.225~236 (2019), Springer
- Khosravi Bakhtiari M, "Effects of citral on serum antioxidant status and liver genes expressions of paraoxonase 1 and nitric oxide synthase in a rat model of streptozotocin-induced diabetes mellitus", Iran J Vet Res, 22(3), pp.195~202 (2021)
- Li CC, "Effects of lemongrass oil and citral on hepatic drug-metabolizing enzymes, oxidative stress, and acetaminophen toxicity in rats", J Food Drug Anal, 26(1), pp.432~438 (2018)
- Nakamura Y, "A phase II detoxification enzyme inducer from lemongrass : identification of citral and involvement of electrophilic reaction in the enzyme induction", Biochem Biophys Res Commun, 302(3), pp.593~600 (2003)
- Shen Y, "Citral inhibits lipopolysaccharide-induced acute lung injury by activating PPAR-γ", Eur J Pharmacol, 747, pp.45~51 (2015)
- Abenavoli L, "Milk thistle(Silybum marianum) : a concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases", Phytother Res, 32(11), pp.2202~2213 (2018)
- Karimi G, "“Silymarin”, a promising pharmacological agent for treatment of diseases", Iran J Basic Med Sci, 14(4), pp.308~317 (2011)
- Razavi-Azarkhiavi K, "Silymarin alleviates bleomycin-induced pulmonary toxicity and lipid peroxidation in mice", Pharm Biol, 52(10), pp.1267~1271 (2014)
- Mohamed AE, "Potential therapeutic effect of thymoquinone and", or bee pollen on fluvastatin-induced hepatitis in rats, 2021, pp.11(1), 15688~
- Boskabady M, "Thymoquinone ameliorates lung inflammation and pathological changes observed in lipopolysaccharide-induced lung injury", Evid Based Complement Alternat Med, 2021, pp.6681729~ (2021)
- Almalki RS, "Methotrexate toxicity : molecular mechanisms and management", J Pharm Res Int, 33(49B), pp.204~217 (2021)
- Cannon GW, "Methotrexate pulmonary toxicity", Rheum Dis Clin North Am, 23(4), pp.917~937 (1997)
- Zeller JM, "Effects of high-dose methotrexate on rat alveolar and inflammatory macrophage populations", Inflammation, 8(3), pp.231~239 (1984)
- Thaniyan A, "Histopathological features of methotrexate induced pulmonary lesions in rheumatoid arthritis patients : a systematic review of case reports", Open Access Maced J Med Sci, 5(2), pp.266~270 (2017)
- Jakubovic BD, "Methotrexate-induced pulmonary toxicity", Can Respir J, 20(3), pp.153~155 (2013)
- Ünver E, "Effect of rutin on methotrexate-induced oxidative lung injury in rats : a biochemical and histopathological evaluation", Lat Am J Pharm, 40(9), pp.2260~2266 (2021)
- Renad Mammadov, "Effect of lutein on methotrexate-induced oxidative lung damage in rats: a biochemical and histopathological assessment", The Korean Journal of Internal Medicine, 34(6), pp.1279~1286 (2019), 대한내과학회[DOI]
- Ahmed ST, "The histological effects of methotrexate on the lungs of albino rats : an experimental study", Eur J Mol Clin Med, 8(1), pp.1289~1296 (2021)
- Toklu HZ, "Silymarin, the antioxidant component of Silybum marianum, prevents sepsis-induced acute lung and brain injury", J Surg Res, 145(2), pp.214~222 (2008)
- Chen CH, "Synergistic anti-cancer effect of baicalein and silymarin on human hepatoma HepG2 Cells", Food Chem Toxicol, 47(3), pp.638~644 (2009)
- Nazemian F, "Effect of silymarin administration on TNF-α serum concentration in peritoneal dialysis patients", Phytother Res, 24(11), pp.1654~1657 (2010)
- Ahmed RF, "Ameliorative effects of silymarin on HCl-induced acute lung injury in rats; role of the Nrf-2", HO-1 pathway, 2019, pp.22(12), 1483~1492
- Al-Hazmi A, "Antioxidant activity of silymarin in microcystin-LR cardiac and pulmonary induced injuries on mice", Pak J Biol Sci, 23(11), pp.1369~1373 (2020)
- Long N, "Effect and mechanism of citral against methicillin-resistant Staphylococcus aureus in vivo", J Sci Food Agric, 99(9), pp.4423~4429 (2019)
- Alzohairy MA, "Protective effects of thymoquinone, an active compound of Nigella sativa, on rats with benzo(a)pyrene-induced lung injury through regulation of oxidative stress and inflammation", Molecules, 26(11), pp.3218~ (2021)
- Abdo W, "Protective effect of thymoquinone against lung intoxication induced by malathion inhalation", Sci Rep, 11(1), pp.2498~ (2021)
- Pourgholamhossein F, "Thymoquinone effectively alleviates lung fibrosis induced by paraquat herbicide through down-regulation of pro-fibrotic genes and inhibition of oxidative stress", Environ Toxicol Pharmacol, 45, pp.340~345 (2016)
- El-Khouly D, "Thymoquinone blocks lung injury and fibrosis by attenuating bleomycin-induced oxidative stress and activation of nuclear factor Kappa-B in rats", Toxicology, 302(2-3), pp.106~113 (2012)